Sebastian Hoffmann
Overview
Explore the profile of Sebastian Hoffmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1920
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thiel J, Bauer M, Daigeler A, Kavaka V, Kolbenschlag J, Steiner D, et al.
Ther Adv Med Oncol
. 2025 Feb;
17:17588359251317842.
PMID: 39975512
Background: Radiation-associated angiosarcoma of the breast (RAASB) is a rare secondary angiosarcoma that typically develops subsequent to breast-conserving therapy for breast cancer. The parameters of the resection width and depth...
2.
Hoffmann S, Hoffmann T, Potkrajcic V, Deinzer C, Benzler K, Zender L, et al.
World J Surg Oncol
. 2025 Jan;
23(1):10.
PMID: 39773479
Objective: To assess the tolerability of multimodal therapy in soft tissue sarcoma patients, particularly with regard to their quality of life and level of distress. Materials And Methods: A retrospective...
3.
Hoffmann S, Berger B, Lucas L, Schiele F, Park J
Cells
. 2025 Jan;
13(24.
PMID: 39768175
Membrane proteins, especially extracellular domains, are key therapeutic targets due to their role in cell communication and associations. Yet, their functions and interactions often remain unclear. This study presents a...
4.
Hoffmann S, Loy J, Farber S, Krischer M
Prax Kinderpsychol Kinderpsychiatr
. 2024 Dec;
73(8):700-718.
PMID: 39623915
School Absence as Functional Impairment of Juveniles with Personality Disorders Based on ICD-11 This longitudinal study focused on the question whether specialized treatment with applied transference focused psychotherapy in a...
5.
Aali G, Porter A, Hoffmann S, Longnecker M, Shokraneh F
F1000Res
. 2024 Oct;
12:1595.
PMID: 39411687
Background: Per- and polyfluoroalkyl substances (PFAS) were used or are being used in the manufacturing of products, including consumer-use products. The resulting environmental contamination has led to widespread human exposure....
6.
Thiel J, Bamberg M, Daigeler A, Fontana J, Hoffmann S, Illg C, et al.
Life (Basel)
. 2024 Sep;
14(9).
PMID: 39337883
Large bone defects of the distal radius and/or carpus following tumor resection, trauma, or infection are extremely rare. There are few case reports and series in the literature on the...
7.
Svendsen C, Mathisen G, Vist G, Husoy T, Ames H, Beronius A, et al.
Evid Based Toxicol
. 2024 Sep;
2(1).
PMID: 39239089
The focus on implementation of systematic review (SR) principles in chemical risk assessments (CRAs) is growing as it has the potential to advance the rigour and transparency of the CRAs....
8.
Tourneix F, Carron L, Jouffe L, Hoffmann S, Alepee N
Toxics
. 2024 Aug;
12(8).
PMID: 39195638
Regulations of cosmetic ingredients and products have been the most advanced in embracing new approach methodologies (NAMs). Consequently, the cosmetic industry has assumed a forerunner role in the development and...
9.
Mathisen G, Bearth A, Jones L, Hoffmann S, Vist G, Ames H, et al.
Arch Toxicol
. 2024 Jun;
98(8):2299-2308.
PMID: 38877155
No abstract available.
10.
Beausoleil C, Thebault A, Andersson P, Cabaton N, Ermler S, Fromenty B, et al.
Toxicol Appl Pharmacol
. 2024 Jun;
489:116995.
PMID: 38862081
Identification of Endocrine-Disrupting Chemicals (EDCs) in a regulatory context requires a high level of evidence. However, lines of evidence (e.g. human, in vivo, in vitro or in silico) are heterogeneous...